| 摘要 |
This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, <IMAGE> (I) wherein R and R1 are identical or different and stand for a hydrogen or halogen atom, a nitro or a C1-4 alkoxy group, R2 stands for a hydrogen atom or a C1-4 alkyl group, R3 and R4 are identical or different and stand for a hydrogen atom or a C1-4 alkyl group, or R3 and R4 combined denote a methylene group, with the proviso that when R stands for 3-methoxy, R1 for 4-methoxy, R3 and R4 are identical and represent methyl or ethyl groups, R2 is other than hydrogen atom. The compounds of the general formula (I) exert valuable positive inotropic (cardiotonic) potency, they are capable to increase the myocardiac contractile force (heart performance in cardiac insufficiency), thus they can be applied in the therapy of chronic heart failure and coronary ailments. |
